期刊
CLINICAL INFECTIOUS DISEASES
卷 63, 期 7, 页码 954-958出版社
OXFORD UNIV PRESS INC
DOI: 10.1093/cid/ciw398
关键词
NDM; CRE; ceftazidime-avibactam; bacteremia; carbapenemase
Resistance to the novel beta-lactam/beta-lactamase inhibitor combination ceftazidime-avibactam (CAZ-AVI) among carbapenem-resistant Enterobacteriaceae (CRE) has infrequently been reported in the United States. We report unexpectedly high rates of resistance to CAZ-AVI in CRE bloodstream isolates at our institution associated with the nonoutbreak spread of New Delhi metallo-beta-lactamase in diverse Enterobacteriaceae species.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据